The Beauty Health CompanySKINNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
35.73%
↑ 293% above average
Average (23q)
9.10%
Historical baseline
Range
High:105.79%
Low:-58.71%
Volatility
1808.4%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 35.73% |
| Q2 2025 | 25.35% |
| Q1 2025 | -18.33% |
| Q4 2024 | 10.29% |
| Q3 2024 | -4.40% |
| Q2 2024 | -58.71% |
| Q1 2024 | -7.85% |
| Q4 2023 | 65.63% |
| Q3 2023 | -36.17% |
| Q2 2023 | 23.33% |
| Q1 2023 | 61.55% |
| Q4 2022 | -33.27% |
| Q3 2022 | -16.69% |
| Q2 2022 | 16.64% |
| Q1 2022 | 18.93% |
| Q4 2021 | -0.27% |
| Q3 2021 | -37.08% |
| Q2 2021 | 105.79% |
| Q1 2021 | 68.84% |
| Q4 2020 | 49.05% |
| Q3 2020 | -3.35% |
| Q2 2020 | -56.61% |
| Q1 2020 | 9.90% |
| Q4 2019 | 0.00% |